申请人:HOECHST JAPAN LIMITED
                            
                            
                                公开号:EP0413278A2
                            
                            
                                公开(公告)日:1991-02-20
                            
                            
Therapeutic agents for the treatment of peptic ulcer disease, containing as active ingredient, at least one compound of the general formula I
 wherein one of R¹ and R³ is
 (wherein m is 1-5 R⁴ represents a (C₁-C₄)alkyl group); the other one of R¹ and R³ is hydrogen, (C₃-C₆)alkenyl or (C₁-C₈)alkyl which can be substituted with up to 2 hydroxyl groups or a (C₁-C₄)alkoxy group; and R² is (C₁-C₄)alkyl.
                            用于治疗消化性溃疡病的治疗剂,含有至少一种通式 I 的化合物作为活性成分
 其中 R¹ 和 R³ 之一为
 (其中 m 为 1-5 R⁴ 代表 (C₁-C₄)烷基);R¹ 和 R³ 的另一个是氢、(C₃-C₆)烯基或可被最多 2 个羟基或 (C₁-C₄) 烷氧基取代的 (C₁-C₄) 烷基;以及 R² 是 (C₁-C₄)烷基。